United Therapeutics (NASDAQ: UTHR) pushes inhaled therapy strategy as Phase 3 Tyvaso data shows lung function preservation in IPF
Read More 2 minute read Healthcare Industry News Baxter to acquire Seprafilm Adhesion Barrier from Sanofi for $350m Baxter International, a US-based health care company, has signed a deal worth $350 million to acquire Seprafilm Adhesion… bypharmanewsdailyJanuary 2, 2020
